JRP
SGMT icon

Jasper Ridge Partners’s Sagimet Biosciences SGMT Stock Holding History

Jasper Ridge Partners’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.2K Hold
12,865
– – ﹤0.01% 139
2025
Q4 		$76.2K Sell
12,865
-6,135
-32% -$44.1K ﹤0.01% 136
2025
Q3 		$130K Hold
19,000
– – ﹤0.01% 138
2025
Q2 		$145K Hold
19,000
– – ﹤0.01% 138
2025
Q1 		$61.9K Buy
+19,000
New +$79.7K ﹤0.01% 140

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jasper Ridge Partners's SGMT Position: Q1 2026 in Review

Jasper Ridge Partners held its Sagimet Biosciences (SGMT) position steady in Q1 2026 at 12,865 shares worth $67.2K. The position accounts for ﹤0.01% of the portfolio, ranked #139.

Jasper Ridge Partners first reported a position in SGMT in Q1 2025 and has held it in 5 quarters since. The position peaked at $145K in Q2 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Jasper Ridge Partners held 12,865 shares of Sagimet Biosciences worth $67.2K as of Q1 2026.
  • Jasper Ridge Partners left its Sagimet Biosciences share count unchanged in Q1 2026.
  • Sagimet Biosciences made up ﹤0.01% of Jasper Ridge Partners's portfolio in Q1 2026, its #139 holding.
  • Jasper Ridge Partners first reported a position in Sagimet Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Jasper Ridge Partners's Sagimet Biosciences position peaked at $145K in Q2 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Jasper Ridge Partners's 13F filing for Q1 2026, filed 11 May 2026.